AnodyneWiki

Levomethamphetamine

Levomethamphetamine
Levomethamphetamine
Salts
[]
Levomethamphetamine hydrochloride
Levomethamphetamine hydrochloride
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass149.23 g/mol [1]
Predicted LogP2.1 [1]
Structural Identifiers
[]
Molecular formulaC10H15N
IUPAC name(2R)-N-methyl-1-phenylpropan-2-amine
SMILESC[C@H](CC1=CC=CC=C1)NC
InChIInChI=1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3/t9-/m1/s1
InChIKeyMYWUZJCMWCOHBA-SECBINFHSA-N
CAS number33817-09-3
UNIIY24T9BT2Q2
PubChem CID36604
Pharmacokinetics[]
Elimination half-life10–15 hours
MetabolismLiver (CYP2D6)
ExcretionUrine (41–49% unchanged, 2–3% as levoamphetamine)
Routes of administrationMedical: Intranasal, Recreational: By mouth, intravenous, insufflation, inhalation, suppository

Levomethamphetamine (also known as L-Methamphetamine, l-Methylamphetamine, R(-)-N-Methylamphetamine, l-1-Phenyl-2-methylaminopropane, Vicks, Levmetamfetamine cii, levmetanfetamina, l-1-Phenyl-2-methylamino-propan, Benzeneethanamine, N,α-dimethyl-, (R)- or Benzeneethanamine, N,α-dimethyl-, (-)-) is a stimulant substance of the amphetamine class.

Chemistry

Salts []

Levomethamphetamine is typically found in the form of its hydrochloride salt.

 []

Levomethamphetamine is a single defined stereoisomer (optical activity ( - )).

Levomethamphetamine matches Lipinski's rule of five.

Pharmacology

Mechanism of action []

Levomethamphetamine crosses the blood-brain-barrier and acts as a TAAR1 agonist,[3] functioning as a selective norepinephrine releasing agent in the central nervous system, [1]

Subjective effects []

 []

  • Australia: Levomethamphetamine is a Schedule 8.
  • Brazil: Levomethamphetamine is a F2.[3]
  • Canada: Levomethamphetamine is a Schedule I.
  • United Kingdom: Levomethamphetamine is a Class A under the "Misuse of Drugs Act 1971".
  • United States: Levomethamphetamine is a Schedule II and for specific formulations OTC under the "Controlled Substances Act".
  • United Nations: Levomethamphetamine is a Psychotropic Schedule II.
  • Germany: Levomethamphetamine is a Anlage II under the "Betäubungsmittelgesetz (BtMG)".
  • Other: Levomethamphetamine is a SE: Förteckning I.

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 36604, Levomethamphetamine. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/36604
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Levomethamphetamine. UNII: Y24T9BT2Q2. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/Y24T9BT2Q2
  3. RDC Nº 877 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 28 May 2024. https://www.in.gov.br/en/web/dou/-/resolucao-da-diretoria-colegiada-anvisa-n-877-de-28-de-maio-de-2024-562758149

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 08:01:31
drugspromissing (no DrugsPRO reagent data)2026-11-20 08:01:27
erowidmissing (no Erowid substance of that name)2026-11-20 08:01:27
gsrsok2026-11-20 08:01:28
hmdbmissing (no HMDB id)2026-11-20 08:01:27
keggmissing (no KEGG DRUG entry)2026-11-20 08:01:31
pubchemok2026-11-20 08:01:27
redditmissing (no r/tripreports posts mention it)2026-11-20 08:01:27
sidermissing (not in SIDER)2026-11-20 08:01:27
structureok2026-11-20 08:01:27
wikipediaok2026-11-20 08:01:28